Alcolase
PrivateLast Round
Seed
May 17, 2026
Total Funding Raised
$1.7M
Momentum Score
25 /100
Company Overview
Alcolase is a biotechnology company developing an enzyme-based supplement to manage alcohol intolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alcolase Comps
Public and private peers based on sector, stage, and business model.
Alcolase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 17, 2026 |
Key People
Founding team and executive leadership
Alcolase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ada Ventures | Seed |
| Delphinus Venture Capital | Seed |
| Antler AI Disrupt | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
$1.5M round led by Ada Ventures, Antler, and Delphinus Venture Capital.
Alcolase Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alcolase's valuation, stock price, and market status.
